Cost-effectiveness analysis in diagnosis of cardiac disease: Overview of its rationale and method

Journal of Nuclear Cardiology

Volumn 3, Issue 4, 1996, Pages 334-341

  Patterson, Randolph E ^a,b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Carlyle Fraser Heart Center   (United States)

Author keywords

Cardiac imaging; Cost effectiveness; Health services research; Medical economics; Nuclear cardiology, coronary artery disease; Patient outcomes; Quality of care; Stress test; Technology assessment

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CORONARY ARTERY DISEASE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; MALE; MEDICAL TECHNOLOGY; POLICY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0029739780     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(96)90094-X     Document Type: Review

References (50)

1. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977; 296:716-21.
2. Doubliet P, Weinstein MC, McNeil BJ. Use and misuse of the term "cost-effective" in medicine. N Engl J Med 1986;314:253-6.
3. McNeil BJ, Varady PD, Burrows BA, Adelstein SJ. Measures of clinical efficacy: cost-effectiveness calculations in the diagnosis and treatment of hypertensive renovascular disease. N Engl J Med 1975;293:216-21.
4. Ellwood P. Special report: Shattuck guest lecture: outcome management, a technology of patient experience. N Engl J Med 1988;18:1549-56.
5. Sox HC Jr, Blatt MA, Higgins MC, Martin KI. Medical decision making. Boston: Butterworths, 1988:147-201; 317-36.
6. Pettiti DB. Meta-analysis, decision analysis, and cost-effectiveness analysis; methods for quantitative synthesis in medicine. New York: Oxford University Press, 1994:246.
7. Kupersmith J, Homes-Rovner M, Hogan A, Rovner D, Gardiner J. Cost-effectiveness analysis in heart disease, part I: general principles. Prog Cardiovasc Dis 1994;37:161-84.
8. Eisenberg JM. Clinical economics: a guide to the economic analysis of clinical practices (state of the art review). JAMA 1989;262:2879-86.
9. Risenberg D. Economics is everybody's business. JAMA 1989; 262:2897.
10. Eckholm E. The technology imperative: solving America's health care crisis. New York: New York Times, 1993:69-76.
11. Task Force on Principles for Economic Analysis of Health Care Technology. Economic analysis of health care technology: a report on principles. Ann Intern Med 1995;122:61-70.
12. Evans RE. Manufacturing concensus, marketing truth: guidelines for economic evaluation. Ann Intern Med 1995;123:59-60.
13. Diamond GA, Denton TA. Alternative perspectives on the biased foundations of medical technology assessment. Ann Intern Med 1993;118:455-64.
14. Phelps CE. The methodologic foundations of studies of the appropriateness of medical care. N Engl J Med 1993;329: 1241-5.
15. Roper WL, Winkenwerder W, Hackbarth GM, Krakauer H. Effectiveness in health care: an initiation to evaluate and improve medical practice. N Engl J Med 1988;319:1197-202.
16. Enthoven AC. Shattuck lecture: cutting costs without cutting the quality of care. N Engl J Med 1978;298:1229-38.
17. Weinstein MC, Fineberg HV, Elstein AS, Frazier HS, Heuhauser D, Neutra RR, et al. Clinical decisions and limited resources. In: Clinical decision analysis. Philadelphia: WB Saunders, 1980:228-65.
18. Kaplan RM, Ganiats TG. QALY's: their ethical implications. JAMA 1990;264:2503.
19. Patterson RE, Eng C, Horowitz SF, et al. Bayesian comparison of cost-effectiveness of different clinical approaches to diagnose coronary artery disease. J Am Coll Cardiol 1984;4:278-89.
20. Willerson JT. Diagnostic methods in the assessment of the patient with chest pain. J Am Coll Cardiol 1984;4:290-1.
21. Marcus FI. A critical appraisal of the Bayesian approach to diagnose coronary artery disease. J Am Coll Cardiol 1984;4: 292-3.
22. Drummond MF, Stoddard GL, Torrance GW. Methods for the economic evaluation of health care programs. New York: Oxford University Press, 1987:1-182.
23. Lusted LB. Introduction to medical decision-making. Springfield, Illinois: Charles C Thomas, 1968:1-46.
24. Pauker SG, Kassirer JP. Decision analysis. N Engl J Med 1987; 316:250-8.
25. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med 1979;30:1350-8.
26. Patterson RE, Horowitz SF, Eng C, Rudin A, Meller J, Halgash DA, et al. Can exercise electrocardiography and thallium-201 myocardial imaging exclude the diagnosis of coronary artery disease? Am J Cardiol 1982;49:1127-35.
27. Patterson RE, Horowitz SF. Importance of epidemiology and biostatistics in deciding clinical strategies for using diagnostic tests: a simplified approach using examples from coronary artery disease. J Am Coll Cardiol 1989;13:1653-65.
28. Chalmers TC, Levin H, Sacks HS, Reitman D, Berrier J, Nagahngam R. Meta-analysis of clinical trials as a scientific discipline, I: control of bias and comparison with large cooperative trials. Stat Med 1987;6:315-25.
29. Eddy DM, Hasselblad V, Schachter R. An introduction to a Bayesian method for meta-analysis: the confidence profile method. Med Decis Making 1990;10:15-23.
30. Detsky AS, Naglie IG. A clinicians guide to cost-effectiveness analysis. Ann Intern Med 1990;113:147-54.
31. Iskandrian AS. Cost-effectiveness analysis for management of patients with ischemic heart disease. J Nucl Cardiol 1995;2:544-6.
32. Bell RS. Efficacy . . . what's that? Semin Nucl Med 1978;8:316-23.
33. Patterson RE, Eisner RL, Horowitz SF. Comparison of cost-effectiveness and utility of exercise ECG, SPECT, PET and coronary angiography for diagnosis of coronary artery disease. Circulation 1995;91:54-65.
34. Drummond MF. Resource allocation decisions in health care: a role for quality of life assessments. J Chron Dis 1987;40:605-16.
35. Froberg DG, Kane RL. Methodology for measuring health-state preferences, I: measurement strategies. J Clin Epidemiol 1989;42: 345-54.
36. Finkler SA. The distinction between costs and charges. Ann Intern Med 1982;96:102-9.
37. Johannesson M. On the discounting of gained life-years in cost-effectiveness analysis. Int J Technol Assess Health Care 1992;8: 359-64.
38. Jollis JG, Aucukiewicz M, DeLong ER, Pryor DB, Muhlbaier LH, Mark DB. Discordance of databases designed for claims payment versus clinical information systems: implications for outcomes research. Ann Intern Med 1993;119:844-50.
39. Rifkin RD, Hood WB Jr. Bayesian analysis of electrocardiographic exercise stress testing. N Engl J Med 1977;207:681-6.
40. Weiner DA, Ryan TJ, McCabe CH, et al. Exercise stress testing: correlations among history of angina, ST segment response and prevalence of coronary artery disease in the Coronary Artery Surgery Study (CASS). N Engl J Med 1979;301:230-5.
41. Feinstein AR. The haze of Bayes', the aerial palaces of decision analysis and the computerized Quija board. Clin Pharmacol Ther 1979;21:482-95.
42. Weintraub WS, Maderia SW Jr, Bodenheimer MS, et al. Critical analysis of the application of Bayes' theorem to sequential testing in the noninvasive diagnosis of coronary artery disease. Am J Cardiol 1984;54:43-9.
43. Hlatky MA, Pryor DB, Ahrrell FE, Califf RM, Mark DB, Rosati RA. Factors affecting sensitivity and specificity of exercise electrocardiography: multivariate analysis. Am J Med 1984;77:64-71.
44. Fryback DG. Bayes' theorem and conditional nonindependence of data in medical diagnosis. Comput Biomed Res 1978;11:423-31.
45. Diamond GA, Staniloff HM, Forrester JS, Pollock BH, Swan HJC. Computer-assisted diagnosis in the noninvasive evaluation of patients with suspected coronary artery disease. J Am Coll Cardiol 1983;1:444-55.
46. Pryor DB, Harrell FF, Lee KI, Califf RM, Rosati RA. Estimating the likelihood of significant coronary artery disease. Am J Med 1983;75:771-80.
47. McKean R. Efficiency in government through systems analysis. New York: John Wiley & Sons, 1958:21-96.
48. Goldman L. Cost-effectiveness strategies in cardiology. In: Braunwald E, ed. Heart disease: a textbook of cardiovascular medicine. 4th ed. Philadelphia: WB Saunders, 1992:1694-707.
49. Weinstein MC, Stason WB. Cost-effectiveness of interventions to prevent or treat heart disease. Ann Rev Public Health 1985;263: 408-13.
50. Patterson RE, Horowitz SF, Eisner RL. Comparison of modalities to diagnose coronary artery disease. Semin Nucl Med 1994;24: 286-310.